🎁 Black Friday: up to 50% off of annual plans
IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.8006
-0.1965 (-19.71%)
At close: Nov 20, 2026, 4:00 PM EST
0.8505
+0.0499 (6.23%)
After-hours: Nov 20, 2026, 7:58 PM EST

IceCure Medical Stock Forecast

ICCM's stock price has decreased by -96.19% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, IceCure Medical stock has a consensus rating of "Strong Buy" and an average price target of $20.33. The average 1-year stock price forecast is 2,439.35% higher than the current stock price, while the lowest is $3.00 (+274.72%) and the highest is $30 (+3,647.19%).

Price Target: $20.33 (+2,439.35%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$3.00$20.33$28$30
Change+274.72%+2439.3%+3397.4%+3647.2%

Analyst Ratings

The average analyst rating for IceCure Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26May '26Jun '26Aug '26Oct '26Nov '26
Strong Buy122222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total233333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Reiterates
$10 → $3
BuyReiterates$10 → $3+274.72%Nov 20, 2026
Brookline Capital Markets
Brookline Capital Markets
Buy
Maintains
$74
BuyMaintains$74+9,080.61%Jun 17, 2026
Alliance Global Partners
Alliance Global Partners
Buy
Maintains
$30
BuyMaintains$30+3,647.19%May 13, 2026

Financial Forecast

Revenue This Year
3.91M
from 3.38M
Increased by 15.69%
Revenue Next Year
8.26M
from 3.91M
Increased by 111.25%
EPS This Year
-4.64
from -7.20
EPS Next Year
-2.74
from -4.64
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
4.14M3.09M3.23M3.29M3.38M3.91M
Revenue Growth
6.98%-25.45%4.67%1.92%2.67%15.69%
Gross Profit
2.20M1.45M1.30M1.45M1.23M1.41M
Gross Margin
53.04%46.84%40.26%44.09%36.28%35.97%
Operating Income
-9.72M-16.74M-15.58M-15.70M-15.09M-17.34M
Net Income
-9.90M-16.98M-14.65M-15.32M-15.06M-17.20M
EPS
-----7.20-4.64
Free Cash Flow
-----14.61M-14.21M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.9M
Avg3.9M
Low3.9M

Revenue Growth

Revenue Growth202620272028
High
16.7%
Avg
15.7%
Low
14.7%

EPS Forecast

EPS202620272028
High-4.64
Avg-4.64
Low-4.64

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-